Lv7
3720 积分 2023-06-27 加入
Cyclin-dependent kinase 2 (CDK2)
1天前
已完结
Next steps for targeted protein degradation
2天前
已完结
Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics
2天前
已完结
Targeted protein degradation: from mechanisms to clinic
2天前
已完结
Delivering on the promise of protein degraders
2天前
已完结
Protein degraders enter the clinic — a new approach to cancer therapy
2天前
已完结
How multispecific molecules are transforming pharmacotherapy
3天前
已完结
Advances in the treatment of systemic lupus erythematosus
3天前
已完结
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
9天前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
10天前
已完结
皖公网安备34019202002308
